BILLERICA, MA – January 19, 2016 - Insulet Corporation (NASDAQ: PODD) (Insulet or the
Company), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management
System (OmniPod System), today announced that is has donated $10,000 each to the American
Diabetes Association (ADA) and the Juvenile Diabetes Research Foundation (JDRF). Insulet
employees raised the funds for these charitable donations during November’s National Diabetes
Awareness Month as part of a company-sponsored three-day initiative in which thousands of
clinicians across the U.S. wore a demo of the OmniPod System. Insulet made a donation to either
the ADA or JDRF for each clinician who participated in the program.
“Our mission is to improve the lives of individuals living with diabetes,” said Patrick Sullivan,
President and Chief Executive Officer. “The successful fundraising efforts by the employees of
Insulet underscore their creativity, dedication and commitment to this very important cause. We
are grateful for the participation of clinicians across the U.S. in support of our fundraising
campaign. We are proud to donate to the ADA and JDRF and look forward to continuing to work
closely with these organizations.”
Shacey Petrovic, Insulet’s Chief Commercial Officer, presented checks to representatives from the
ADA and JDRF this week at a recent Insulet event.
“We are grateful for this generous donation from Insulet and its employees, which will help
advance our cutting-edge research efforts aimed to prevent, cure and manage all types of diabetes,”
said Jonathan Webb, Vice President, Corporate Alliances and Grants, American Diabetes
Association. “Thanks to decades of critical research made possible through generous supporters
like Insulet, people with diabetes are living longer, healthier and more comfortable lives. But as
we celebrate advances, we also promise to never let down our guard in both the fight against
diabetes and the fight for all people affected by diabetes.”
JDRF works tirelessly to find life-changing breakthroughs to cure, prevent and treat type 1 diabetes
and its complications,” said Margo K. Lucero, Senior Vice President, Corporate and International
Development of JDRF. “We graciously accept this donation from Insulet and its employees who
share our desire to not only research for tomorrow, but find the best possible diabetes treatments
for today.”